Lataa...
The contact activation system as a potential therapeutic target in patients with COVID‐19
Coronavirus disease 2019 (COVID‐19) is predicted to overwhelm health care capacity in the United States and worldwide, and, as such, interventions that could prevent clinical decompensation and respiratory compromise in infected patients are desperately needed. Excessive cytokine release and activat...
Tallennettuna:
| Julkaisussa: | Res Pract Thromb Haemost |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7264624/ https://ncbi.nlm.nih.gov/pubmed/32542210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12349 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|